A Review of Characteristics, Properties, Application of Nanocarriers and Analytical Methods of Luliconazole

Porto, Douglas; Bajerski, Lisiane; Malesuik, Marcelo Donadel; Paim, Clésio Soldateli

doi:10.1080/10408347.2021.1926219

Cited by 6 publications

(1 citation statement)

References 44 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…It is highly lipophilic, but proper nanocarriers can enhance its solubility and permeability that improve the therapeutic effect. In addition, luliconazole has a broad-spectrum antifungal activity making this fungicide a promising future antifungal agent in clinics (Dos Santos Porto et al, 2021 ).…”

Section: Conclusion and Future Remarksmentioning

confidence: 99%

Trans-kingdom fungal pathogens infecting both plants and humans, and the problem of azole fungicide resistance

Pintye,

Bacsó,

Kovács

2024

Front. Microbiol.

View full text Add to dashboard Cite

Azole antifungals are abundantly used in the environment and play an important role in managing fungal diseases in clinics. Due to the widespread use, azole resistance is an emerging global problem for all applications in several fungal species, including trans-kingdom pathogens, capable of infecting plants and humans. Azoles used in agriculture and clinics share the mode of action and facilitating cross-resistance development. The extensive use of azoles in the environment, e.g., for plant protection and wood preservation, contributes to the spread of resistant populations and challenges using these antifungals in medical treatments. The target of azoles is the cytochrome p450 lanosterol 14-α demethylase encoded by the CYP51 (called also as ERG11 in the case of yeasts) gene. Resistance mechanisms involve mainly the mutations in the coding region in the CYP51 gene, resulting in the inadequate binding of azoles to the encoded Cyp51 protein, or mutations in the promoter region causing overexpression of the protein. The World Health Organization (WHO) has issued the first fungal priority pathogens list (FPPL) to raise awareness of the risk of fungal infections and the increasingly rapid spread of antifungal resistance. Here, we review the main issues about the azole antifungal resistance of trans-kingdom pathogenic fungi with the ability to cause serious human infections and included in the WHO FPPL. Methods for the identification of these species and detection of resistance are summarized, highlighting the importance of these issues to apply the proper treatment.

show abstract

Section: Conclusion and Future Remarksmentioning

confidence: 99%